Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response

BACKGROUND/AIMS: Erlotinib and gemcitabine combined chemotherapy is becoming the treatment of choice in advanced pancreatic cancer. We evaluated the effectiveness of treatment with erlotinib plus gemcitabine and the prognostic factors for chemotherapeutic response in Korean pancreatic cancer patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, Semi, Chung, Moon Jae, Park, Jeong Youp, Chung, Jae Bock, Bang, Seungmin, Park, Seung Woo, Song, Si Young
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782678/
https://ncbi.nlm.nih.gov/pubmed/24073321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2013.7.5.611
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados